Tonix Pharm Holdings (TNXP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Sales | 13,544 | 6,878 | 5,390 | 3,290 | 1,998 |
| Cost of Goods | 703 | 1,578 | 1,058 | 1,367 | 3,272 |
| Gross Profit | 12,841 | 5,300 | 4,332 | 1,923 | -1,274 |
| Operating Expenses | 56,079 | 47,415 | 52,676 | 35,357 | 27,294 |
| Operating Income | -42,535 | -41,537 | -48,286 | -33,067 | -28,296 |
| Other Income | 1,983 | 1,343 | 1,376 | 1,057 | 24 |
| Pre-tax Income | -40,552 | -40,194 | -46,910 | -32,010 | -28,272 |
| Net Income Continuous | -40,552 | -40,194 | -46,910 | -32,010 | -28,272 |
| Net Income | $-40,552 | $-40,194 | $-46,910 | $-32,010 | $-28,272 |
| EPS Basic Total Ops | -2.44 | -2.93 | -4.28 | -3.59 | -3.86 |
| EPS Basic Continuous Ops | -2.44 | -2.93 | -4.29 | -3.59 | -3.86 |
| EPS Diluted Total Ops | -2.44 | -2.93 | -4.28 | -3.59 | -3.86 |
| EPS Diluted Continuous Ops | -2.44 | -2.93 | -4.29 | -3.59 | -3.86 |
| EPS Diluted Before Non-Recurring Items | -2.44 | -2.93 | -3.98 | -3.59 | -3.86 |
| EBITDA(a) | $-41,916 | $-40,982 | $-47,798 | $-32,606 | $-27,813 |